Get started
Author

Míriam Andrés

V1b and CRHR1 Receptor Heterodimerization Mediates Synergistic Biological Actions of Vasopressin and CRH
2012 · Brigitte Murat, Dominic Devost, et al. · Molecular Endocrinology · 53
PDF
Vasopressin Receptors in Human Adrenal Medulla and Pheochromocytoma1
1999 · Eric Grazzini, Christophe Breton, et al. · The Journal of Clinical Endocrinology & Metabolism · 44
Pharmacological characterization of F‐180: a selective human V1a vasopressin receptor agonist of high affinity
2002 · Miriam Andrés, Miguel Trueba, et al. · British Journal of Pharmacology · 33
PDF
Synthesis and Biological Activity of Pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidines as Phosphodiesterase Type 4 Inhibitors
2010 · Joan Taltavull, Jordi Serrat, et al. · Journal of Medicinal Chemistry · 31
Biphenyl Pyridazinone Derivatives as Inhaled PDE4 Inhibitors: Structural Biology and Structure–Activity Relationships
2016 · Jordi Gràcia, Maria Antonia Buil, et al. · Journal of Medicinal Chemistry · 27
Biaryl analogues of teriflunomide as potent DHODH inhibitors
2011 · Montse Erra, Imma Moreno, et al. · Bioorganic & Medicinal Chemistry Letters · 23
4-Amino-7,8-dihydro-1,6-naphthyridin-5(6H)-ones as Inhaled Phosphodiesterase Type 4 (PDE4) Inhibitors: Structural Biology and Structure–Activity Relationships
2018 · Richard S. Roberts, Sara Sevilla, et al. · Journal of Medicinal Chemistry · 19
Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of pyrrolopiperidinone acetic acids as CRTh2 antagonists
2014 · Miriam Andrés, Maria Antonia Buil, et al. · Bioorganic & Medicinal Chemistry Letters · 19
Synthesis and biological activity of pyrido[3′,2′:4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors
2011 · Joan Taltavull, Jordi Serrat, et al. · European Journal of Medicinal Chemistry · 18
Purification of a cortisol binding protein from hepatic plasma membrane
1996 · Iñaki Ibarrola, Miriam Andrés, et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 18
2-(1H-Pyrazol-4-yl)acetic acids as CRTh2 antagonists
2013 · Miriam Andrés, Mónica Bravo, et al. · Bioorganic & Medicinal Chemistry Letters · 13
Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms
2004 · Miriam Andrés, Ana Peña, et al. · European Journal of Pharmacology · 13
Pharmacological characterization of CRTh2 antagonist LAS191859: Long receptor residence time translates into long-lasting in vivo efficacy
2016 · Marta Calbet, Miriam Andrés, et al. · Pharmacological Research · 12
2-(1H-Pyrazol-1-yl)acetic acids as chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes (CRTh2) antagonists
2014 · Miriam Andrés, Mónica Bravo, et al. · European Journal of Medicinal Chemistry · 12
Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists III: The role of a hydrogen-bond acceptor in long receptor residence times
2014 · Juan Antonio Alonso, Miriam Andrés, et al. · Bioorganic & Medicinal Chemistry Letters · 10
Application of a phenotypic drug discovery strategy to identify biological and chemical starting points for inhibition of TSLP production in lung epithelial cells
2018 · Adelina Orellana, Vicente García-González, et al. · PLoS ONE · 9
PDF
Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists I
2014 · Juan Antonio Alonso, Miriam Andrés, et al. · Bioorganic & Medicinal Chemistry Letters · 9
Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists II: Lead optimization
2014 · Juan Antonio Alonso, Miriam Andrés, et al. · Bioorganic & Medicinal Chemistry Letters · 5
Identification of novel small molecule-based strategies of COL7A1 upregulation and readthrough activity for the treatment of recessive dystrophic epidermolysis bullosa
2024 · Irene Jover, Maria C. Ramos, et al. · Scientific Reports · 3
PDF
Works count: 19
Citation count: 371
H-index: 12
I10-index: 15
Year
Topic
Type